申请人:Consejo Superior de Investigaciones Científicas
(CSIC)
公开号:EP3772355A1
公开(公告)日:2021-02-10
The invention relates to a bifunctional compound that is, on one side, an agonist of the TLR4 and, on the other side, an important inhibitor of the PSMA. Said compound is useful in immunotherapy for the treatment and/or prevention of prostate cancer. Therefore, the invention also relates to the use of the compound and to the pharmaceutical composition comprising it.
本发明涉及一种双功能化合物,它一方面是 TLR4 的激动剂,另一方面又是 PSMA 的重要抑制剂。所述化合物可用于治疗和/或预防前列腺癌的免疫疗法。因此,本发明还涉及该化合物的用途以及包含该化合物的药物组合物。